查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1275633

照護現場(PoC)診斷的全球市場:各平台、用途、樣品類型、終端用戶 - 預測(～2030年)

Point-of-Care Diagnostics Market by Platform (LFA, Molecular), Application (TB, Pneumonia, Salmonellosis, Hepatitis, HIV, COVID-19, Pregnancy, Blood Glucose Monitoring, Hematology, Tumor), Sample Type (Blood, Urine), and End User-Global Forecast to 2030
出版日期: | 出版商: Meticulous Research | 英文 395 Pages | 訂單完成後即時交付

價格

全球照護現場(PoC)診斷的市場規模，預計到2030年達到431億美元，2023年～2030年預計以5.1％的年複合成長率成長。市場成長起因於對主要成本效率高的PoC檢驗的需求劇增，及COVID-19發生，對PoC診斷檢驗的資金提供增加等。

本報告提供全球照護現場(PoC)診斷市場相關調查分析，市場趨勢的考察，地區和市場區隔的評估，競爭情形等資訊。

目錄

第1章 市場定義和範圍

第2章 調查手法

第3章 摘要整理

第4章 市場考察

  • 概要
  • 促進因素
  • 阻礙因素
  • 機會
  • 課題
  • 技術趨勢
  • 法規分析
    • 美國
    • 加拿大
    • 歐洲
    • 中國
    • 日本
    • 南美
    • 沙烏地阿拉伯
  • 價格分析

第5章 照護現場(PoC)診斷市場評估:各提供

  • 概要
  • 消耗品
  • 器具
  • 軟體和服務

第6章 照護現場(PoC)診斷市場評估:各平台

  • 概要
  • 側流化驗
  • 分子診斷
  • 其他的平台

第7章 照護現場(PoC)診斷市場評估:各用途

  • 概要
  • 血糖監測系統
  • 傳染病檢查
    • 寄生蟲傳染病檢查
    • 血源性傳染病檢查
    • 呼吸系統傳染病檢查
    • 醫療相關感染(HAI)檢驗
    • 腸胃傳染病檢查
    • 其他的傳染病檢查
  • COVID-19檢驗
  • 腫瘤/癌症標記檢驗
  • 妊娠和不孕的檢驗
    • 妊娠檢驗
    • 不孕檢驗
  • 心臟標記/心臟代謝檢驗
  • 膽固醇/脂質簡介檢驗
  • 血液凝固檢驗
    • 凝血酵素原時間(PT/INR)檢驗
    • 活性化凝固時間(ACT/APTT)檢驗
    • 其他的血液凝固檢驗
  • 血液
  • 藥物濫用檢測
  • 尿液檢查
  • 其他的PoC檢驗

第8章 照護現場(PoC)診斷市場評估:各樣品類型

  • 概要
  • 血液樣品
  • 鼻咽拭子
  • 尿樣品
  • 唾液樣品
  • 其他的樣品類型

第9章 照護現場(PoC)診斷市場評估:各終端用戶

  • 概要
  • 醫院
  • 居家照護/自我檢驗
  • 體檢室，門診病人診療設施
  • 診斷研究所
  • 其他的終端用戶

第10章 照護現場(PoC)診斷市場評估:各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他的歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他的亞太地區
  • 南美
    • 巴西
    • 墨西哥
    • 其他的南美
  • 中東、非洲

第11章 競爭情形

  • 簡介
  • 主要的成長策略
  • 競爭儀表板
    • 產業的領導者
    • 市場差異化要素
    • 先導企業
    • 新興企業
  • 市場佔有率分析(2022年)
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers AG
    • Danaher Corporation
    • Thermo Fisher Scientific, Inc.

第12章 企業簡介

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson and Company (BD)
  • bioMerieux S.A.
  • QuidelOrtho Corporation
  • EKF Diagnostics Holdings plc
  • Sekisui Diagnostics, LLC.
  • Trinity Biotech plc
  • Chembio Diagnostics, Inc.
  • Werfen
  • Nova Biomedical

第13章 附錄

Product Code: MRHC - 10499

The global point-of-care diagnostics market is projected to reach $43.1 billion by 2030, at a CAGR of 5.1% from 2023 to 2030.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report analyzes key industry drivers, restraints, challenges, and opportunities. The growth in the point-of-care diagnostics market is mainly attributed to the rapidly growing demand for cost-efficient PoC tests, the outbreak of COVID-19, and growing funding for PoC diagnostics tests. However, pricing pressure due to fluctuations in reimbursements restrains the growth of this market. Increasing demand for PoC diagnostics in emerging economies is expected to create opportunities in the market.

Based on offering, in 2023, the consumables segment is expected to account for the largest share of the market. Diagnostic kits are designed to provide highly accurate results with minimal risk of user error. They are pre-packaged with all the necessary materials and reagents, ensuring that the correct amounts are used, thus reducing the risk of contamination, contributing to the segment's largest share.

Based on platform, the molecular diagnostics segment is projected to register the highest CAGR during the forecast period. The tests are commonly used for the detection of viruses such as COVID-19 and flu, while LAMP tests are used for the detection of bacteria and viruses, such as tuberculosis and human papillomavirus (HPV). These tests can provide results within 30 minutes to an hour, depending on the complexity of the test and the type of instrument used. The shorter turnaround time of test results drives the market for molecular diagnostics.

Based on application, in 2023, the blood glucose monitoring segment is expected to account for the largest share of the global point-of-care diagnostics market. PoC devices are widely used for monitoring blood glucose levels. These devices offer reliable quantitative results and are portable, inexpensive, and easy to use, driving the segment growth. Additionally, they enable healthcare professionals to make immediate treatment decisions in response to glycemic fluctuations in hospitalized patients and can also be used by diabetic patients at home to monitor their glucose levels frequently.

Based on sample type, in 2023, the blood sample type segment is expected to account for the largest share of the global point-of-care diagnostics market. Blood sample testing has many benefits, such as determining infections and risks for various health conditions, monitoring the status and progression of chronic diseases, checking treatment success, and in some cases, early disease diagnosis, contributing to the largest share of the segment.

Based on end-user, in 2023, the hospital segment is expected to account for the largest share of the global point-of-care diagnostics market. Hospitals perform various tests to diagnose medical conditions and ensure proper clinical treatment and prevention planning. Factors such as the urgency in medical decision-making, increasing healthcare expenditure, rising prevalence of healthcare-associated infections (HAIs), and the rising number of hospitals and clinics across emerging markets are driving the demand for point-of-care diagnostic kits for use in hospitals & clinics.

An in-depth analysis of the geographical scenario of the global point-of-care diagnostics market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the point-of-care diagnostics market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America's large share is attributed to the region's highly developed diagnostics infrastructure, the trend of PoC testing, the high prevalence of chronic diseases coupled with growth in the aging population, the rising number of inpatient admissions, and the high adoption of self-testing kits among the general population.

The key players operating in the global point-of-care diagnostics market are Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), QuidelOrtho Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Chembio Diagnostics, Inc. (U.S.), EKF Diagnostics Holdings plc (U.K.), Trinity Biotech plc (Ireland), Werfen (Spain), Nova Biomedical (U.S.), Sekisui Diagnostics, LLC. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and bioMerieux S.A. (France).

Scope of the Report:

Point-of-Care Diagnostics Market Assessment-by Offering

  • Consumables
  • Instruments
  • Software and Services

Point-of-Care Diagnostics Market Assessment-by Platform

  • Lateral Flow Assays
  • Molecular Diagnostics
  • Other Platforms

(Other platforms include coagulation tests, dipsticks, cholesterol and glucose monitoring systems, and other point-of-care diagnostic platforms)

Point-of-Care Diagnostics Market Assessment-by Application

  • Blood Glucose Monitoring
  • Infectious Disease Testing
    • Parasitic Infection Testing
    • Blood-borne Infection Testing
  • Hepatitis
  • HIV
  • Other Blood-borne Infections
    • Respiratory Infection Testing
  • Influenza
  • Pneumonia
  • Other Respiratory Infection Testing
    • Healthcare-associated Infection (HAI) Testing
    • Gastrointestinal (GI) Infection Testing
  • Salmonellosis
  • E. Coli Infections
  • Other GI Infections
    • Other Infectious Disease Testing
  • COVID-19 Testing
  • Tumor/Cancer Markers Testing
  • Pregnancy And Fertility Testing
    • Pregnancy Testing
    • Fertility Testing
  • Cardiac Marker/Cardiac Metabolism Testing
  • Cholesterol/Lipid Profile Testing
  • Coagulation Testing
    • Prothrombin Time (PT/INR) Testing
    • Activated Clotting Time (ACT/APTT) Testing
    • Other Coagulation Testing
  • Hematology
  • Drugs Of Abuse Testing
  • Urinalysis
  • Other PoC Testing

(Other respiratory infections testing include strep infections and respiratory syncytial virus (RSV). Other GI infections include cholera, Helicobacter pylori (H. pylori), and campylobacteriosis. Other blood-borne diseases include syphilis and brucellosis. Other infectious disease testing includes meningitis, hand, foot, and mouth disease (HFMD), and mononucleosis. Other coagulation testing includes fibrinogen level and platelet count. Other PoC testing includes tropical diseases and sexually transmitted diseases)

Point-of-Care Diagnostics Market Assessment-by Sample Type

  • Blood Sample
  • Nasopharyngeal swab
  • Urine Sample
  • Saliva Sample
  • Other Sample Types

(Other sample types include stool, cervical swab, buccal swab, hair, vaginal swab, and semen)

Point-of-Care Diagnostics Market Assessment-by End User

  • Hospitals
  • Home care/self-testing
  • Physician Offices & Ambulatory Care Settings
  • Diagnostics Laboratories
  • Other End User

(Other end users include nursing homes, long-term care centers, pharmacies, urgent care facilities, schools, airports, hotels, and workplaces)

Point-of-Care Diagnostics Market Assessment-by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Rest of Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Market Definition & Scope

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitation
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Process of Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecast
    • 2.3.1. Market Size Estimation Approach
      • 2.3.1.1. Bottom-up Approach
      • 2.3.1.2. Top-down Approach
    • 2.3.2. Growth Forecast Approach
    • 2.3.3. Market Share Analysis
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Drivers
    • 4.2.1. Increasing Prevalence of Chronic Diseases
    • 4.2.2. Innovations in PoC Tests
    • 4.2.3. Development of CLIA-waived PoC Tests
    • 4.2.4. Lack of Skilled Technicians for Performing Lab Tests
  • 4.3. Restraints
    • 4.3.1. Pricing Pressure Due to Fluctuations in Reimbursements
  • 4.4. Opportunities
    • 4.4.1. Emerging Markets
    • 4.4.2. Healthcare Professionals' Increasing Preference for PoC Tests Over Other Lab Tests
  • 4.5. Challenges
    • 4.5.1. Lack of Awareness Regarding the Use of PoC Devices
  • 4.6. Technology Trends
    • 4.6.1. Lateral Flow Assays Containing DNA Nanostructures
    • 4.6.2. Rapid Real-time Polymerization Chain Reaction (PCR) Tests
    • 4.6.3. Smartphone-based Detection Platforms
    • 4.6.4. Nanoelectronic Biosensors in Point-of-Care Diagnostics
  • 4.7. Regulatory Analysis
    • 4.7.1. U.S.
    • 4.7.2. Canada
    • 4.7.3. Europe
    • 4.7.4. China
    • 4.7.5. Japan
    • 4.7.6. Latin America
    • 4.7.7. Saudi Arabia
  • 4.8. Pricing Analysis

5. Point-of-Care Diagnostics Market Assessment-by Offering

  • 5.1. Overview
  • 5.2. Consumables
  • 5.3. Instruments
  • 5.4. Software And Services

6. Point-of-Care Diagnostics Market Assessment-by Platform

  • 6.1. Overview
  • 6.2. Lateral Flow Assays
  • 6.3. Molecular Diagnostics
  • 6.4. Other Platforms

7. Point-of-Care Diagnostics Market Assessment-by Application

  • 7.1. Overview
  • 7.2. Blood Glucose Monitoring
  • 7.3. Infectious Disease Testing
    • 7.3.1. Parasitic Infections Testing
    • 7.3.2. Blood-borne Infections Testing
      • 7.3.2.1. Hepatitis
      • 7.3.2.2. HIV
      • 7.3.2.3. Other Blood-borne Infections
    • 7.3.3. Respiratory Infections Testing
      • 7.3.3.1. Influenza
      • 7.3.3.2. Pneumonia
      • 7.3.3.3. Tuberculosis (TB)
      • 7.3.3.4. Other Respiratory Infections Testing
    • 7.3.4. Healthcare-associated Infections (HAI) Testing
    • 7.3.5. Gastrointestinal Infections Testing
      • 7.3.5.1. Salmonellosis
      • 7.3.5.2. E. Coli Infections
      • 7.3.5.3. Other GI Infections
    • 7.3.6. Other Infectious Diseases Testing
  • 7.4. COVID-19 Testing
  • 7.5. Tumor/Cancer Markers Testing
  • 7.6. Pregnancy And Fertility Testing
    • 7.6.1. Pregnancy Testing
    • 7.6.2. Fertility Testing
  • 7.7. Cardiac Marker/Cardiac Metabolism Testing
  • 7.8. Cholesterol/Lipid Profile Testing
  • 7.9. Coagulation Testing
    • 7.9.1. Prothrombin Time (PT/INR) Testing
    • 7.9.2. Activated Clotting Time (ACT/APTT) Testing
    • 7.9.3. Other Coagulation Testing
  • 7.10. Hematology
  • 7.11. Drugs of Abuse Testing
  • 7.12. Urinalysis
  • 7.13. Other PoC Testing

8. Point-of-Care Diagnostics Market Assessment-by Sample Type

  • 8.1. Overview
  • 8.2. Blood Sample
  • 8.3. Nasopharyngeal Swab
  • 8.4. Urine Sample
  • 8.5. Saliva Sample
  • 8.6. Other Sample Types

9. Point-of-Care Diagnostics Market Assessment-by End User

  • 9.1. Overview
  • 9.2. Hospitals
  • 9.3. Home Care/Self-testing
  • 9.4. Physician Offices & Ambulatory Care Settings
  • 9.5. Diagnostics Laboratories
  • 9.6. Other End Users

10. Point-of-Care Diagnostics Market Assessment-by Geography

  • 10.1. Overview
  • 10.2. North America
    • 10.2.1. U.S.
    • 10.2.2. Canada
  • 10.3. Europe
    • 10.3.1. Germany
    • 10.3.2. France
    • 10.3.3. U.K.
    • 10.3.4. Italy
    • 10.3.5. Spain
    • 10.3.6. Rest of Europe
  • 10.4. Asia-Pacific
    • 10.4.1. China
    • 10.4.2. Japan
    • 10.4.3. India
    • 10.4.4. Rest of Asia-Pacific
  • 10.5. Latin America
    • 10.5.1. Brazil
    • 10.5.2. Mexico
    • 10.5.3. Rest of Latin America
  • 10.6. Middle East & Africa

11. Competitive Landscape

  • 11.1. Introduction
  • 11.2. Key Growth Strategies
  • 11.3. Competitive Dashboard
    • 11.3.1. Industry Leaders
    • 11.3.2. Market Differentiators
    • 11.3.3. Vanguards
    • 11.3.4. Emerging Companies
  • 11.4. Market Share Analysis (2022)
    • 11.4.1. Abbott Laboratories
    • 11.4.2. F. Hoffmann-La Roche Ltd
    • 11.4.3. Siemens Healthineers AG
    • 11.4.4. Danaher Corporation
    • 11.4.5. Thermo Fisher Scientific, Inc.

12. Company Profiles

  • 12.1. Abbott Laboratories
  • 12.2. F. Hoffmann-La Roche Ltd
  • 12.3. Siemens Healthineers AG
  • 12.4. Danaher Corporation
  • 12.5. Thermo Fisher Scientific Inc.
  • 12.6. Becton, Dickinson and Company (BD)
  • 12.7. bioMerieux S.A.
  • 12.8. QuidelOrtho Corporation
  • 12.9. EKF Diagnostics Holdings plc
  • 12.10. Sekisui Diagnostics, LLC.
  • 12.11. Trinity Biotech plc
  • 12.12. Chembio Diagnostics, Inc.
  • 12.13. Werfen
  • 12.14. Nova Biomedical

13. Appendix

  • 13.1. Available Customization
  • 13.2. Related Reports

List of Tables

  • Table 1 Global Diabetes Prevalence in People Aged 20-79 Years, by Region, 2021 VS. 2030 VS. 2045 (Million)
  • Table 2 PoC Products with CLIA Waiver
  • Table 3 Percentage of Population Residing in Urban Areas, 2015 VS. 2025 VS. 2050 (Emerging Countries)
  • Table 4 Authorities Regulating In Vitro Diagnostic Products, by Country
  • Table 5 Price Comparison of Point-of-Care Tests
  • Table 6 Price Comparison of Glucose Monitoring Tests
  • Table 7 Global Point-of-Care Diagnostics Market, by Offering, 2021-2030 (USD Million)
  • Table 8 Key Companies Offering Consumables
  • Table 9 Global Point-of-Care Diagnostics Consumables Market, by Country/Region, 2021-2030 (USD Million)
  • Table 10 Key Companies Offering Instruments
  • Table 11 Global Point-of-Care Diagnostics Instruments Market, by Country/Region, 2021-2030 (USD Million)
  • Table 12 Key Companies Offering Software and Services
  • Table 13 Global Point-of-Care Diagnostics Market for Software and Services, by Country/Region, 2021-2030 (USD Million)
  • Table 14 Global Point-of-Care Diagnostics Market, by Platform, 2021-2030 (USD Million)
  • Table 15 Key Companies Offering Lateral Flow Assays
  • Table 16 Global Point-of-Care Diagnostics Market for Lateral Flow Assays, by Country/Region, 2021-2030 (USD Million)
  • Table 17 Key Companies Offering Rapid PCR Test Kits
  • Table 18 Global Point-of-Care Diagnostics Market for Molecular Diagnostics, by Country/Region, 2021-2030 (USD Million)
  • Table 19 Global Point-of-Care Diagnostics Market for Other Platforms, by Country/Region, 2021-2030 (USD Million)
  • Table 20 Global Point-of-Care Diagnostics Market, by Application, 2021-2030
  • Table 21 Number of People with Diabetes Aged 20-79 Years, by Region
  • Table 22 Global Point-of-Care Diagnostics Market for Blood Glucose Monitoring, by Country/Region, 2021-2030 (USD Million)
  • Table 23 Global Point-of-Care Diagnostics Market for Infectious Diseases Testing, by Type, 2021-2030 (USD Million)
  • Table 24 Global Point-of-Care Diagnostics Market for Infectious Diseases Testing, by Country/Region, 2021-2030 (USD Million)
  • Table 25 Global Point-of-Care Diagnostics Market for Parasitic Infections Testing, by Country/Region, 2021-2030 (USD Million)
  • Table 26 Global Point-of-Care Diagnostics Market for Blood-borne Infections Testing, by Type, 2021-2030 (USD Million)
  • Table 27 Global Point-of-Care Diagnostics Market for Blood-borne Infections Testing, by Country/Region, 2021-2030 (USD Million)
  • Table 28 Current and Future Reduction Targets for Hepatitis Infection
  • Table 29 Global Point-of-Care Diagnostics Market for Hepatitis, by Country/Region, 2021-2030 (USD Million)
  • Table 30 HIV Incidence 2020 Vs. 2021
  • Table 31 HIV-related Deaths, 2020 Vs. 2021
  • Table 32 Global Point-of-Care Diagnostics Market for HIV, by Country/Region, 2021-2030 (USD Million)
  • Table 33 Global Point-of-Care Diagnostics Market for Other Blood-borne Infections, by Country/Region, 2021-2030 (USD Million)
  • Table 34 Global Point-of-Care Diagnostics Market for Respiratory Infections Testing, by Country/Region, 2021-2030 (USD Million)
  • Table 35 Rapid Influenza Diagnostic Tests (RIDTs)
  • Table 36 Global Point-of-Care Diagnostics Market for Influenza, by Country/Region, 2021-2030 (USD Million)
  • Table 37 Global Point-of-Care Diagnostics Market for Pneumonia, by Country/Region, 2021-2030 (USD Million)
  • Table 38 Global Point-of-Care Diagnostics Market for Tuberculosis, by Country/Region, 2021-2030 (USD Million)
  • Table 39 Global Point-of-Care Diagnostics Market for Other Respiratory Infections Testing, by Country/Region, 2021-2030 (USD Million)
  • Table 40 Global PoC Diagnostics Market for Healthcare-associated Infection (HAI) Testing,by Country/Region, 2021-2030 (USD Million)
  • Table 41 Global Point-of-Care Diagnostics Market for Gastrointestinal Infections Testing, by Type, 2021-2030 (USD Million)
  • Table 42 Global Point-of-Care Diagnostics Market for Gastrointestinal Infections Testing, by Country/Region, 2021-2030 (USD Million)
  • Table 43 Global Point-of-Care Diagnostics Market for Salmonellosis, by Country/Region, 2021-2030 (USD Million)
  • Table 44 Global Point-of-Care Diagnostics Market for E. Coli Infections, by Country/Region, 2021-2030 (USD Million)
  • Table 45 Global Point-of-Care Diagnostics Market for Other GI Infections, by Country/Region, 2021-2030 (USD Million)
  • Table 46 Global Point-of-Care Diagnostics Market for Other Infectious Diseases Testing, by Country/Region, 2021-2030 (USD Million)
  • Table 47 Recently Launched and Approved Rapid Diagnostic Tests for COVID-19 Detection
  • Table 48 FDA-Authorized At-Home OTC COVID-19 Diagnostic Tests
  • Table 49 Global Point-of-Care Diagnostics Market for COVID-19 Testing, by Country/Region, 2021-2030 (USD Million)
  • Table 50 Key Companies Offering Tumor/Cancer Marker Testing Products
  • Table 51 Global Point-of-Care Diagnostics Market for Tumor/Cancer Markers Testing, by Country/Region, 2021-2030 (USD Million)
  • Table 52 Global Point-of-Care Diagnostics Market for Pregnancy and Fertility Testing, by Type, 2021-2030 (USD Million)
  • Table 53 Global Point-of-Care Diagnostics Market for Pregnancy and Fertility Testing, by Country/Region, 2021-2030 (USD Million)
  • Table 54 Key Companies Offering Point-of-Care Diagnostic Kits for Pregnancy Testing
  • Table 55 Global Point-of-Care Diagnostics Market for Pregnancy Testing, by Country/Region, 2021-2030 (USD Million)
  • Table 56 Key Companies Offering Point-of-Care Diagnostic Kits for Fertility Testing
  • Table 57 Global Point-of-Care Diagnostics Market for Fertility Testing, by Country/Region, 2021-2030 (USD Million)
  • Table 58 Key Companies Offering Point-of-Care Diagnostic Kits for Cardiac Metabolism Testing
  • Table 59 Global PoC Diagnostics Market for Cardiac Marker/Cardiac Metabolism Testing, by Country/Region, 2021-2030 (USD Million)
  • Table 60 Global Point-of-Care Diagnostics Market for Cholesterol/Lipid Profile Testing, by Country/Region, 2021-2030 (USD Million)
  • Table 61 Global Point-of-Care Diagnostics Market for Coagulation Testing, by Type, 2021-2030 (USD Million)
  • Table 62 Global Point-of-Care Diagnostics Market for Coagulation Testing, by Country/Region, 2021-2030 (USD Million)
  • Table 63 Global Point-of-Care Diagnostics Market for Prothrombin Time (PT/INR) Testing, by Country/Region, 2021-2030 (USD Million)
  • Table 64 Global PoC Market for Activated Clotting Time (ACT/APTT) Testing, by Country/Region, 2021-2030 (USD Million)
  • Table 65 Global Point-of-Care Diagnostics Market for Other Coagulation Testing, by Country/Region, 2021-2030 (USD Million)
  • Table 66 Global Point-of-Care Diagnostics Market for Hematology, by Country/Region, 2021-2030 (USD Million)
  • Table 67 Global Point-of-Care Diagnostics Market for Drugs of Abuse Testing, by Country/Region, 2021-2030 (USD Million)
  • Table 68 Global Point-of-Care Diagnostics Market for Urinalysis, by Country/Region, 2021-2030 (USD Million)
  • Table 69 Incidence of Tropical Diseases (2019)
  • Table 70 Global Point-of-Care Diagnostics Market for Other PoC Testing, by Country/Region, 2021-2030 (USD Million)
  • Table 71 Global Point-of-Care Diagnostics Market, by Sample Type, 2021-2030
  • Table 72 Global Point-of-Care Diagnostics Market for Blood Sample, by Country/Region, 2021-2030 (USD Million)
  • Table 73 Global Point-of-Care Diagnostics Market for Nasopharyngeal Swab, by Country/Region, 2021-2030 (USD Million)
  • Table 74 Reason for Conducting a Urine Test
  • Table 75 Global Point-of-Care Diagnostics Market for Urine Sample, by Country/Region, 2021-2030 (USD Million)
  • Table 76 PoC Devices for Salivary Biomarkers
  • Table 77 Global Point-of-Care Diagnostics Market for Saliva Sample, by Country/Region, 2021-2030 (USD Million)
  • Table 78 Sample Type for Various Test
  • Table 79 Global Point-of-Care Diagnostics Market for Other Sample Types, by Country/Region, 2021-2030 (USD Million)
  • Table 80 Global Point-of-Care Diagnostics Market, by End User, 2021-2030 (USD Million)
  • Table 81 Global Point-of-Care Diagnostics Market for Hospitals, by Country/Region, 2021-2030 (USD Million)
  • Table 82 Global Point-of-Care Diagnostics Market for Home Care/Self-testing, by Country/Region, 2021-2030 (USD Million)
  • Table 83 Global PoC Market for Physician Offices & Ambulatory Care Settings, by Country/Region, 2021-2030 (USD Million)
  • Table 84 Global Point-of-Care Diagnostics Market for Diagnostic Laboratories, by Country/Region, 2021-2030 (USD Million)
  • Table 85 Global Point-of-Care Diagnostics Market for Other End Users, by Country/Region, 2021-2030 (USD Million)
  • Table 86 Point-of-Care Diagnostics Market, by Country/Region, 2021-2030 (USD Million)
  • Table 87 North America: Point-of-Care Diagnostics Market, by Country, 2021-2030
  • Table 88 North America: Point-of-Care Diagnostics Market, by Offering, 2021-2030
  • Table 89 North America: Point-of-Care Diagnostics Market, by Platform, 2021-2030
  • Table 90 North America: Point-of-Care Diagnostics Market, by Application, 2021-2030 (USD Million)
  • Table 91 North America: Infectious Diseases Testing Market, by Type, 2021-2030
  • Table 92 North America: Respiratory Infections Market, by Type, 2021-2030 (USD Million)
  • Table 93 North America: Gastrointestinal Infections Market, by Type, 2021-2030
  • Table 94 North America: Blood-Borne Infections Market, by Type, 2021-2030 (USD Million)
  • Table 95 North America: Coagulation Testing Market, by Type, 2021-2030 (USD Million)
  • Table 96 North America: Pregnancy and Fertility Testing Market, by Type, 2021-2030
  • Table 97 North America: Point-of-Care Diagnostics Market, by Sample Type, 2021-2030 (USD Million)
  • Table 98 North America: Point-of-Care Diagnostics Market, by End User, 2021-2030
  • Table 99 Rapid Diagnostic Kits Launched for Coronavirus Testing
  • Table 100 U.S.: Point-of-Care Diagnostics Market, by Offering, 2021-2030 (USD Million)
  • Table 101 U.S.: Point-of-Care Diagnostics Market, by Platform, 2021-2030 (USD Million)
  • Table 102 U.S.: Point-of-Care Diagnostics Market, by Application, 2021-2030 (USD Million)
  • Table 103 U.S.: Infectious Diseases Testing Market, by Type, 2021-2030 (USD Million)
  • Table 104 U.S.: Respiratory Infections Market, by Type, 2021-2030 (USD Million)
  • Table 105 U.S.: Gastrointestinal Infections Market, by Type, 2021-2030 (USD Million)
  • Table 106 U.S.: Blood-Borne Infections Market, by Type, 2021-2030 (USD Million)
  • Table 107 U.S.: Coagulation Testing Market, by Type, 2021-2030 (USD Million)
  • Table 108 U.S.: Pregnancy and Fertility Testing Market, by Type, 2021-2030 (USD Million)
  • Table 109 U.S.: Point-of-Care Diagnostics Market, by Sample Type, 2021-2030 (USD Million)
  • Table 110 U.S.: Point-of-Care Diagnostics Market, by End User, 2021-2030 (USD Million)
  • Table 111 Canada: Point-of-Care Diagnostics Market, by Offering, 2021-2030 (USD Million)
  • Table 112 Canada: Point-of-Care Diagnostics Market, by Platform, 2021-2030 (USD Million)
  • Table 113 Canada: Point-of-Care Diagnostics Market, by Application, 2021-2030 (USD Million)
  • Table 114 Canada: Infectious Diseases Testing Market, by Type, 2021-2030 (USD Million)
  • Table 115 Canada: Respiratory Infections Market, by Type, 2021-2030 (USD Million)
  • Table 116 Canada: Gastrointestinal Infections Market, by Type, 2021-2030 (USD Million)
  • Table 117 Canada: Blood-Borne Infections Market, by Type, 2021-2030 (USD Million)
  • Table 118 Canada: Coagulation Testing Market, by Type, 2021-2030 (USD Million)
  • Table 119 Canada: Pregnancy and Fertility Testing Market, by Type, 2021-2030 (USD Million)
  • Table 120 Canada: Point-of-Care Diagnostics Market, by Sample Type, 2021-2030 (USD Million)
  • Table 121 Canada: Point-of-Care Diagnostics Market, by End User, 2021-2030 (USD Million)
  • Table 122 Europe: Point-of-Care Diagnostics Market, by Country/Region, 2021-2030 (USD Million)
  • Table 123 Europe: Point-of-Care Diagnostics Market, by Offering, 2021-2030 (USD Million)
  • Table 124 Europe: Point-of-Care Diagnostics Market, by Platform, 2021-2030 (USD Million)
  • Table 125 Europe: Point-of-Care Diagnostics Market, by Application, 2021-2030 (USD Million)
  • Table 126 Europe: Infectious Diseases Testing Market, by Type, 2021-2030 (USD Million)
  • Table 127 Europe: Respiratory Infections Market, by Type, 2021-2030 (USD Million)
  • Table 128 Europe: Gastrointestinal Infections Market, by Type, 2021-2030 (USD Million)
  • Table 129 Europe: Blood-Borne Infections Market, by Type, 2021-2030 (USD Million)
  • Table 130 Europe: Coagulation Testing Market, by Type, 2021-2030 (USD Million)
  • Table 131 Europe: Pregnancy and Fertility Testing Market, by Type, 2021-2030 (USD Million)
  • Table 132 Europe: Point-of-Care Diagnostics Market, by Sample Type, 2021-2030
  • Table 133 Europe: Point-of-Care Diagnostics Market, by End User, 2021-2030 (USD Million)
  • Table 134 Recent Initiatives by the German Government to Tackle the COVID-19 Pandemic
  • Table 135 Germany: Point-of-Care Diagnostics Market, by Offering, 2021-2030 (USD Million)
  • Table 136 Germany: Point-of-Care Diagnostics Market, by Platform, 2021-2030 (USD Million)
  • Table 137 Germany: Point-of-Care Diagnostics Market, by Application, 2021-2030 (USD Million)
  • Table 138 Germany: Infectious Diseases Testing Market, by Type, 2021-2030 (USD Million)
  • Table 139 Germany: Respiratory Infections Market, by Type, 2021-2030 (USD Million)
  • Table 140 Germany: Gastrointestinal Infections Market, by Type, 2021-2030 (USD Million)
  • Table 141 Germany: Blood-Borne Infections Market, by Type, 2021-2030 (USD Million)
  • Table 142 Germany: Coagulation Testing Market, by Type, 2021-2030 (USD Million)
  • Table 143 Germany: Pregnancy and Fertility Testing Market, by Type, 2021-2030 (USD Million)
  • Table 144 Germany: Point-of-Care Diagnostics Market, by Sample Type, 2021-2030 (USD Million)
  • Table 145 Germany: Point-of-Care Diagnostics Market, by End User, 2021-2030 (USD Million)
  • Table 146 France: Point-of-Care Diagnostics Market, by Offering, 2021-2030 (USD Million)
  • Table 147 France: Point-of-Care Diagnostics Market, by Platform, 2021-2030 (USD Million)
  • Table 148 France: Point-of-Care Diagnostics Market, by Application, 2021-2030 (USD Million)
  • Table 149 France: Infectious Diseases Testing Market, by Type, 2021-2030 (USD Million)
  • Table 150 France: Respiratory Infections Market, by Type, 2021-2030 (USD Million)
  • Table 151 France: Gastrointestinal Infections Market, by Type, 2021-2030 (USD Million)
  • Table 152 France: Blood-Borne Infections Market, by Type, 2021-2030 (USD Million)
  • Table 153 France: Coagulation Testing Market, by Type, 2021-2030 (USD Million)
  • Table 154 France: Pregnancy and Fertility Testing Market, by Type, 2021-2030 (USD Million)
  • Table 155 France: Point-of-Care Diagnostics Market, by Sample Type, 2021-2030 (USD Million)
  • Table 156 France: Point-of-Care Diagnostics Market, by End User, 2021-2030 (USD Million)
  • Table 157 Recent Initiatives by the U.K. Government to Combat the COVID-19 Pandemic
  • Table 158 U.K.: Point-of-Care Diagnostics Market, by Offering, 2021-2030 (USD Million)
  • Table 159 U.K.: Point-of-Care Diagnostics Market, by Platform, 2021-2030 (USD Million)
  • Table 160 U.K.: Point-of-Care Diagnostics Market, by Application, 2021-2030 (USD Million)
  • Table 161 U.K.: Infectious Diseases Testing Market, by Type, 2021-2030 (USD Million)
  • Table 162 U.K.: Respiratory Infections Market, by Type, 2021-2030 (USD Million)
  • Table 163 U.K.: Gastrointestinal Infections Market, by Type, 2021-2030 (USD Million)
  • Table 164 U.K.: Blood-Borne Infections Market, by Type, 2021-2030 (USD Million)
  • Table 165 U.K.: Coagulation Testing Market, by Type, 2021-2030 (USD Million)
  • Table 166 U.K.: Pregnancy and Fertility Testing Market, by Type, 2021-2030 (USD Million)
  • Table 167 U.K.: Point-of-Care Diagnostics Market, by Sample Type, 2021-2030 (USD Million)
  • Table 168 U.K.: Point-of-Care Diagnostics Market, by End User, 2021-2030 (USD Million)
  • Table 169 Initiatives Undertaken by the Government of Italy to Tackle the COVID-19 Pandemic
  • Table 170 Italy: Point-of-Care Diagnostics Market, by Offering, 2021-2030 (USD Million)
  • Table 171 Italy: Point-of-Care Diagnostics Market, by Platform, 2021-2030 (USD Million)
  • Table 172 Italy: Point-of-Care Diagnostics Market, by Application, 2021-2030 (USD Million)
  • Table 173 Italy: Infectious Diseases Testing Market, by Type, 2021-2030 (USD Million)
  • Table 174 Italy: Respiratory Infections Market, by Type, 2021-2030 (USD Million)
  • Table 175 Italy: Gastrointestinal Infections Market, by Type, 2021-2030 (USD Million)
  • Table 176 Italy: Blood-Borne Infections Market, by Type, 2021-2030 (USD Million)
  • Table 177 Italy: Coagulation Testing Market, by Type, 2021-2030 (USD Million)
  • Table 178 Italy: Pregnancy and Fertility Testing Market, by Type, 2021-2030 (USD Million)
  • Table 179 Italy: Point-of-Care Diagnostics Market, by Sample Type, 2021-2030 (USD Million)
  • Table 180 Italy: Point-of-Care Diagnostics Market, by End User, 2021-2030 (USD Million)
  • Table 181 Spain: Point-of-Care Diagnostics Market, by Offering, 2021-2030 (USD Million)
  • Table 182 Spain: Point-of-Care Diagnostics Market, by Platform, 2021-2030 (USD Million)
  • Table 183 Spain: Point-of-Care Diagnostics Market, by Application, 2021-2030 (USD Million)
  • Table 184 Spain: Infectious Diseases Testing Market, by Type, 2021-2030 (USD Million)
  • Table 185 Spain: Respiratory Infections Market, by Type, 2021-2030 (USD Million)
  • Table 186 Spain: Gastrointestinal Infections Market, by Type, 2021-2030 (USD Million)
  • Table 187 Spain: Blood-Borne Infections Market, by Type, 2021-2030 (USD Million)
  • Table 188 Spain: Coagulation Testing Market, by Type, 2021-2030 (USD Million)
  • Table 189 Spain: Pregnancy and Fertility Testing Market, by Type, 2021-2030 (USD Million)
  • Table 190 Spain: Point-of-Care Diagnostics Market, by Sample Type, 2021-2030 (USD Million)
  • Table 191 Spain: Point-of-Care Diagnostics Market, by End User, 2021-2030 (USD Million)
  • Table 192 COVID-19 Cases in European Countries
  • Table 193 Rest of Europe: Point-of-Care Diagnostics Market, by Offering, 2021-2030 (USD Million)
  • Table 194 Rest of Europe: Point-of-Care Diagnostics Market, by Platform, 2021-2030 (USD Million)
  • Table 195 Rest of Europe: Point-of-Care Diagnostics Market, by Application, 2021-2030 (USD Million)
  • Table 196 Rest of Europe: Infectious Diseases Testing Market, by Type, 2021-2030 (USD Million)
  • Table 197 Rest of Europe: Respiratory Infections Market, by Type, 2021-2030 (USD Million)
  • Table 198 Rest of Europe: Gastrointestinal Infections Market, by Type, 2021-2030 (USD Million)
  • Table 199 Rest of Europe: Blood-Borne Infections Market, by Type, 2021-2030 (USD Million)
  • Table 200 Rest of Europe: Coagulation Testing Market, by Type, 2021-2030 (USD Million)
  • Table 201 Rest of Europe: Pregnancy and Fertility Testing Market, by Type, 2021-2030 (USD Million)
  • Table 202 Rest of Europe: Point-of-Care Diagnostics Market, by Sample Type, 2021-2030 (USD Million)
  • Table 203 Rest of Europe: Point-of-Care Diagnostics Market, by End User, 2021-2030
  • Table 204 Asia-Pacific: Point-of-Care Diagnostics Market, by Country/Region, 2021-2030 (USD Million)
  • Table 205 Asia-Pacific: Point-of-Care Diagnostics Market, by Offering, 2021-2030 (USD Million)
  • Table 206 Asia-Pacific: Point-of-Care Diagnostics Market, by Platform, 2021-2030 (USD Million)
  • Table 207 Asia-Pacific: Point-of-Care Diagnostics Market, by Application, 2021-2030 (USD Million)
  • Table 208 Asia-Pacific: Infectious Diseases Testing Market, by Type, 2021-2030 (USD Million)
  • Table 209 Asia-Pacific: Respiratory Infections Market, by Type, 2021-2030 (USD Million)
  • Table 210 Asia-Pacific: Gastrointestinal Infections Market, by Type, 2021-2030 (USD Million)
  • Table 211 Asia-Pacific: Blood-Borne Infections Market, by Type, 2021-2030 (USD Million)
  • Table 212 Asia-Pacific: Coagulation Testing Market, by Type, 2021-2030 (USD Million)
  • Table 213 Asia-Pacific: Pregnancy and Fertility Testing Market, by Type, 2021-2030 (USD Million)
  • Table 214 Asia-Pacific: Point-of-Care Diagnostics Market, by Sample Type, 2021-2030 (USD Million)
  • Table 215 Asia-Pacific: Point-of-Care Diagnostics Market, by End User, 2021-2030 (USD Million)
  • Table 216 China: Mass Testing Drives to Control the Spread of COVID-19 Infections
  • Table 217 China: Point-of-Care Diagnostics Market, by Offering, 2021-2030 (USD Million)
  • Table 218 China: Point-of-Care Diagnostics Market, by Platform, 2021-2030 (USD Million)
  • Table 219 China: Point-of-Care Diagnostics Market, by Application, 2021-2030 (USD Million)
  • Table 220 China: Infectious Diseases Testing Market, by Type, 2021-2030 (USD Million)
  • Table 221 China: Respiratory Infections Market, by Type, 2021-2030 (USD Million)
  • Table 222 China: Gastrointestinal Infections Market, by Type, 2021-2030 (USD Million)
  • Table 223 China: Blood-Borne Infections Market, by Type, 2021-2030 (USD Million)
  • Table 224 China: Coagulation Testing Market, by Type, 2021-2030 (USD Million)
  • Table 225 China: Pregnancy and Fertility Testing Market, by Type, 2021-2030 (USD Million)
  • Table 226 China: Point-of-Care Diagnostics Market, by Sample Type, 2021-2030 (USD Million)
  • Table 227 China: Point-of-Care Diagnostics Market, by End User, 2021-2030 (USD Million)
  • Table 228 Japan: Point-of-Care Diagnostics Market, by Offering, 2021-2030 (USD Million)
  • Table 229 Japan: Point-of-Care Diagnostics Market, by Platform, 2021-2030 (USD Million)
  • Table 230 Japan: Point-of-Care Diagnostics Market, by Application, 2021-2030 (USD Million)
  • Table 231 Japan: Infectious Diseases Testing Market, by Type, 2021-2030 (USD Million)
  • Table 232 Japan: Respiratory Infections Market, by Type, 2021-2030 (USD Million)
  • Table 233 Japan: Gastrointestinal Infections Market, by Type, 2021-2030 (USD Million)
  • Table 234 Japan: Blood-Borne Infections Market, by Type, 2021-2030 (USD Million)
  • Table 235 Japan: Coagulation Testing Market, by Type, 2021-2030 (USD Million)
  • Table 236 Japan: Pregnancy and Fertility Testing Market, by Type, 2021-2030 (USD Million)
  • Table 237 Japan: Point-of-Care Diagnostics Market, by Sample Type, 2021-2030 (USD Million)
  • Table 238 Japan: Point-of-Care Diagnostics Market, by End User, 2021-2030 (USD Million)
  • Table 239 Recent Initiatives Launched by the Government of India to Combat The COVID-19 Pandemic
  • Table 240 India: Point-of-Care Diagnostics Market, by Offering, 2021-2030 (USD Million)
  • Table 241 India: Point-of-Care Diagnostics Market, by Platform, 2021-2030 (USD Million)
  • Table 242 India: Point-of-Care Diagnostics Market, by Application, 2021-2030 (USD Million)
  • Table 243 India: Infectious Diseases Testing Market, by Type, 2021-2030 (USD Million)
  • Table 244 India: Respiratory Infections Market, by Type, 2021-2030 (USD Million)
  • Table 245 India: Gastrointestinal Infections Market, by Type, 2021-2030 (USD Million)
  • Table 246 India: Blood-Borne Infections Market, by Type, 2021-2030 (USD Million)
  • Table 247 India: Coagulation Testing Market, by Type, 2021-2030 (USD Million)
  • Table 248 India: Pregnancy and Fertility Testing Market, by Type, 2021-2030 (USD Million)
  • Table 249 India: Point-of-Care Diagnostics Market, by Sample Type, 2021-2030(USD Million)
  • Table 250 India: Point-of-Care Diagnostics Market, by End User, 2021-2030 (USD Million)
  • Table 251 Rest of Asia-Pacific: Point-of-Care Diagnostics Market, by Offering, 2021-2030 (USD Million)
  • Table 252 Rest of Asia-Pacific: Point-of-Care Diagnostics Market, by Platform, 2021-2030 (USD Million)
  • Table 253 Rest of Asia-Pacific: Point-of-Care Diagnostics Market, by Application, 2021-2030 (USD Million)
  • Table 254 Rest of Asia-Pacific: Infectious Diseases Testing Market, by Type, 2021-2030 (USD Million)
  • Table 255 Rest of Asia-Pacific: Respiratory Infections Market, by Type, 2021-2030 (USD Million)
  • Table 256 Rest of Asia-Pacific: Gastrointestinal Infections Market, by Type, 2021-2030 (USD Million)
  • Table 257 Rest of Asia-Pacific: Blood-Borne Infections Market, by Type, 2021-2030 (USD Million)
  • Table 258 Rest of Asia-Pacific: Coagulation Testing Market, by Type, 2021-2030 (USD Million)
  • Table 259 Rest of Asia-Pacific: Pregnancy and Fertility Testing Market, by Type, 2021-2030 (USD Million)
  • Table 260 Rest of Asia-Pacific: Point-of-Care Diagnostics Market, by Sample Type, 2021-2030 (USD Million)
  • Table 261 Rest of Asia-Pacific: Point-of-Care Diagnostics Market, by End User, 2021-2030 (USD Million)
  • Table 262 Latin America: Point-of-Care Diagnostics Market, by Country/Region, 2021-2030 (USD Million)
  • Table 263 Latin America: Point-of-Care Diagnostics Market, by Offering, 2021-2030 (USD Million)
  • Table 264 Latin America: Point-of-Care Diagnostics Market, by Platform, 2021-2030 (USD Million)
  • Table 265 Latin America: Point-of-Care Diagnostics Market, by Application, 2021-2030 (USD Million)
  • Table 266 Latin America: Infectious Diseases Testing Market, by Type, 2021-2030 (USD Million)
  • Table 267 Latin America: Respiratory Infections Market, by Type, 2021-2030 (USD Million)
  • Table 268 Latin America: Gastrointestinal Infections Market, by Type, 2021-2030 (USD Million)
  • Table 269 Latin America: Blood-Borne Infections Market, by Type, 2021-2030 (USD Million)
  • Table 270 Latin America: Coagulation Testing Market, by Type, 2021-2030 (USD Million)
  • Table 271 Latin America: Pregnancy and Fertility Testing Market, by Type, 2021-2030 (USD Million)
  • Table 272 Latin America: Point-of-Care Diagnostics Market, by Sample Type, 2021-2030 (USD Million)
  • Table 273 Latin America: Point-of-Care Diagnostics Market, by End User, 2021-2030 (USD Million)
  • Table 274 Brazil: Point-of-Care Diagnostics Market, by Offering, 2021-2030 (USD Million)
  • Table 275 Brazil: Point-of-Care Diagnostics Market, by Platform, 2021-2030 (USD Million)
  • Table 276 Brazil: Point-of-Care Diagnostics Market, by Application, 2021-2030 (USD Million)
  • Table 277 Brazil: Infectious Diseases Testing Market, by Type, 2021-2030 (USD Million)
  • Table 278 Brazil: Respiratory Infections Market, by Type, 2021-2030 (USD Million)
  • Table 279 Brazil: Gastrointestinal Infections Market, by Type, 2021-2030 (USD Million)
  • Table 280 Brazil: Blood-Borne Infections Market, by Type, 2021-2030 (USD Million)
  • Table 281 Brazil: Coagulation Testing Market, by Type, 2021-2030 (USD Million)
  • Table 282 Brazil: Pregnancy and Fertility Testing Market, by Type, 2021-2030 (USD Million)
  • Table 283 Brazil: Point-of-Care Diagnostics Market, by Sample Type, 2021-2030 (USD Million)
  • Table 284 Brazil: Point-of-Care Diagnostics Market, by End User, 2021-2030 (USD Million)
  • Table 285 Mexico: Point-of-Care Diagnostics Market, by Offering, 2021-2030 (USD Million)
  • Table 286 Mexico: Point-of-Care Diagnostics Market, by Platform, 2021-2030 (USD Million)
  • Table 287 Mexico: Point-of-Care Diagnostics Market, by Application, 2021-2030 (USD Million)
  • Table 288 Mexico: Infectious Diseases Testing Market, by Type, 2021-2030 (USD Million)
  • Table 289 Mexico: Respiratory Infections Market, by Type, 2021-2030 (USD Million)
  • Table 290 Mexico: Gastrointestinal Infections Market, by Type, 2021-2030 (USD Million)
  • Table 291 Mexico: Blood-Borne Infections Market, by Type, 2021-2030 (USD Million)
  • Table 292 Mexico: Coagulation Testing Market, by Type, 2021-2030 (USD Million)
  • Table 293 Mexico: Pregnancy and Fertility Testing Market, by Type, 2021-2030 (USD Million)
  • Table 294 Mexico: Point-of-Care Diagnostics Market, by Sample Type, 2021-2030 (USD Million)
  • Table 295 Mexico: Point-of-Care Diagnostics Market, by End User, 2021-2030 (USD Million)
  • Table 296 Estimated Cancer Incidence
  • Table 297 People (20-79 Y) with Diabetes (In Thousands)
  • Table 298 Rest of Latin America: Point-of-Care Diagnostics Market, by Offering, 2021-2030 (USD Million)
  • Table 299 Rest of Latin America: Point-of-Care Diagnostics Market, by Platform, 2021-2030 (USD Million)
  • Table 300 Rest of Latin America: Point-of-Care Diagnostics Market, by Application, 2021-2030 (USD Million)
  • Table 301 Rest of Latin America: Infectious Diseases Testing Market, by Type, 2021-2030 (USD Million)
  • Table 302 Rest of Latin America: Respiratory Infections Market, by Type, 2021-2030 (USD Million)
  • Table 303 Rest of Latin America: Gastrointestinal Infections Market, by Type, 2021-2030 (USD Million)
  • Table 304 Rest of Latin America: Blood-Borne Infections Market, by Type, 2021-2030 (USD Million)
  • Table 305 Rest of Latin America: Coagulation Testing Market, by Type, 2021-2030 (USD Million)
  • Table 306 Rest of Latin America: Pregnancy and Fertility Testing Market, by Type, 2021-2030 (USD Million)
  • Table 307 Rest of Latin America: Point-of-Care Diagnostics Market, by Sample Type, 2021-2030 (USD Million)
  • Table 308 Rest of Latin America: Point-of-Care Diagnostics Market, by End User, 2021-2030 (USD Million)
  • Table 309 Middle East & Africa: Point-of-Care Diagnostics Market, by Offering, 2021-2030 (USD Million)
  • Table 310 Middle East & Africa: Point-of-Care Diagnostics Market, by Platform, 2021-2030 (USD Million)
  • Table 311 Middle East & Africa: Point-of-Care Diagnostics Market, by Application, 2021-2030 (USD Million)
  • Table 312 Middle East & Africa: Infectious Diseases Testing Market, by Type, 2021-2030 (USD Million)
  • Table 313 Middle East & Africa: Respiratory Infections Market, by Type, 2021-2030 (USD Million)
  • Table 314 Middle East & Africa: Gastrointestinal Infections Market, by Type, 2021-2030 (USD Million)
  • Table 315 Middle East & Africa: Blood-Borne Infections Market, by Type, 2021-2030 (USD Million)
  • Table 316 Middle East & Africa: Coagulation Testing Market, by Type, 2021-2030 (USD Million)
  • Table 317 Middle East & Africa: Pregnancy and Fertility Testing Market, by Type, 2021-2030 (USD Million)
  • Table 318 Middle East & Africa: Point-of-Care Diagnostics Market, by Sample Type, 2021-2030 (USD Million)
  • Table 319 Middle East & Africa: Point-of-Care Diagnostics Market, by End User, 2021-2030 (USD Million)
  • Table 320 Recent Developments, by Company, 2020-2023

List of Figures

  • Figure 1 Research process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
  • Figure 6 Market Size Estimation and Growth Forecast Approach
  • Figure 7 Global Point-of-Care Diagnostics Market, by Offering, 2023 Vs. 2030
  • Figure 8 Global Point-of-Care Diagnostics Market Size, by Sample Type, 2023 Vs. 2030 (USD Million)
  • Figure 9 Global Point-of-Care Diagnostics Market, by Application, 2023 Vs. 2030 (USD Million)
  • Figure 10 Global Point-of-Care Diagnostics Market, by Platform, 2023 Vs. 2030
  • Figure 11 Global Point-of-Care Diagnostics Market, by End User, 2023 Vs. 2030
  • Figure 12 Global Point-of-Care Diagnostics Market, by Geography
  • Figure 13 Impact Analysis of Market Dynamics
  • Figure 14 Global Percentage Share of the Population Aged 65 Years and Above
  • Figure 15 Population Aged 65 years or Over, by Region, 2020 VS. 2030 (In Million)
  • Figure 16 EU Regulatory Pathway - IVDR 2017/746
  • Figure 17 China: Medical Device Classification and Pre-Market Requirements for PoC Diagnostic Devices
  • Figure 18 Global Point-of-Care Diagnostics Market, by Offering, 2023 VS. 2030
  • Figure 19 Global Point-of-Care Diagnostics Market, by Platform, 2023 VS. 2030
  • Figure 20 Global Point-of-Care Diagnostics Market, by Application, 2023 VS. 2030
  • Figure 21 Prevalence of Diabetes Across the World: 2015-2045 (In Million)
  • Figure 22 Estimated Number of New Cancer Cases, by Region, 2020-2040 (In Million)
  • Figure 23 Global Point-of-Care Diagnostics Market, by Sample Type, 2023 VS. 2030
  • Figure 24 Benefits of Saliva Sampling
  • Figure 25 Global Point-of-Care Diagnostics Market, by End User, 2023 VS. 2030
  • Figure 26 U.S.: Home Healthcare Spending, 2015-2026 (USD Million)
  • Figure 27 Point-of-Care Diagnostics Market, by Region, 2023 VS. 2030 (USD Million)
  • Figure 28 North America: Point-of-Care Diagnostics Market Snapshot
  • Figure 29 U.S.: Number of HIV-positive Patients, 2017-2020
  • Figure 30 Canada: Number of People Aged 65 Years and Above, 2018-2022 (In Thousand)
  • Figure 31 Canada: Number of Inpatient Admissions in Acute-Care Hospitals, 2016-2020 (per 100,000 Population)
  • Figure 32 Europe: Point-of-Care Diagnostics Market Snapshot
  • Figure 33 France: Percentage of Population Aged 65 Years and Above, 2016-2020
  • Figure 34 U.K: Estimated Number of Cancer Cases, 2020-2030
  • Figure 35 U.K.: Number of Diabetes and Urogenital, Blood, and Endocrine Diseases Cases - DALYs (Disability-Adjusted Life Years), 2017-2020 (in Thousand)
  • Figure 36 U.K.: Number of People Diagnosed with Sexually Transmitted Infections
  • Figure 37 Italy: Prevalence of Healthcare-Associated Infections in Acute-Care Wards, 2016-2019
  • Figure 38 Italy: Ovarian Cancer Cases: 2018-2030
  • Figure 39 Number of HIV Tests Performed in Catalonia (Spain), 2014-2020
  • Figure 40 Health Expenditure (2015-2020)
  • Figure 41 Asia-Pacific: Point-of-Care Diagnostics Market Snapshot
  • Figure 42 China: Independent Medical Laboratories Market, 2015-2019 (USD Million)
  • Figure 43 Japan: Percentage Growth in the Aging Population (2015-2021)
  • Figure 44 Latin America: Point-of-Care Diagnostics Market Snapshot
  • Figure 45 Brazil: People Living with HIV
  • Figure 46 Key Growth Strategies Adopted by Leading Players (2020-2023)
  • Figure 47 Competitive Dashboard: Point-of-Care Diagnostics Market
  • Figure 48 Market Share Analysis: Point-of-Care Diagnostics Market (2022)
  • Figure 49 Financial Overview: Abbott laboratories (2022)
  • Figure 50 F. Hoffmann-La Roche Ltd: Financial Overview (2022)
  • Figure 51 Siemens Healthineers AG: Financial Overview (2022)
  • Figure 52 Danaher Corporation: Financial Overview (2022)
  • Figure 53 Thermo Fisher Scientific Inc.: Financial Overview (2022)
  • Figure 54 Becton, Dickinson and Company: Financial Overview (2022)
  • Figure 55 bioMerieux S.A.: Financial Overview (2022)
  • Figure 56 QuidelOrtho Corporation: Financial Overview (2022)
  • Figure 57 EKF Diagnostics Holdings plc: Financial Overview (2022)
  • Figure 58 Sekisui Chemical Co., Ltd.: Financial Overview (2021)
  • Figure 59 Trinity Biotech plc: Financial Overview (2021)
  • Figure 60 Chembio Diagnostics: Financial Overview (2021)
  • Figure 61 Werfen: Financial Overview (2021)